本页面由Tiger Trade Technology Pte. Ltd.提供服务

RESONANCE HEALTH LTD

0.043
-0.002-4.44%
成交量:14.02万
成交额:6,030.00
市值:2,041.61万
市盈率:-11.30
高:0.043
开:0.043
低:0.043
收:0.045
52周最高:0.060
52周最低:0.033
股本:4.75亿
流通股本:2.96亿
量比:2.97
换手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-0.004
每股收益(LYR):-0.004
净资产收益率:-17.05%
总资产收益率:-5.19%
市净率:2.17
市盈率(LYR):-11.30

数据加载中...

公司资料

公司名字:
RESONANCE HEALTH LTD
交易所:
ASX
成立时间:
1987
员工人数:
16
公司地址:
141 Burswood Road,Level 1,Burswood,Western Australia,Australia
邮编:
6100
传真:
61 8 9286 5399
简介:
Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials, including clinical measurement, as well as project and data management services, such as reporting, administration, and support. The company serves clinicians for the diagnosis and management of human diseases; and pharmaceutical companies for their clinical trials. Resonance Health Limited is headquartered in Burswood, Australia.